Gilliland Jeter Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Gilliland Jeter Wealth Management's BMY Position: Q2 2026 in Review
Gilliland Jeter Wealth Management sold out of Bristol-Myers Squibb (BMY) in Q2 2026, closing a stake of 3,312 shares — an estimated $201K sold.
Gilliland Jeter Wealth Management first reported a position in BMY in Q4 2023 and held it in 5 quarters. The position peaked at $274K in Q4 2023. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Gilliland Jeter Wealth Management reported no remaining Bristol-Myers Squibb position as of Q2 2026 after selling out during the quarter.
- Gilliland Jeter Wealth Management sold 3,312 Bristol-Myers Squibb shares in Q2 2026, an estimated $201K.
- Gilliland Jeter Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2023 and held it in 5 quarters.
- Gilliland Jeter Wealth Management's Bristol-Myers Squibb position peaked at $274K in Q4 2023.
- 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Gilliland Jeter Wealth Management's 13F filing for Q2 2026, filed 29 Jul 2026.